TMG and MTHFR: Methylation, Folate and B12 Explained

Affiliate disclosure: Biohack Blueprint may earn a commission from qualifying DoNotAge purchases through our links.

TMG supplements and MTHFR are often discussed as if a genetic result automatically determines the right methyl donor. The biology is more specific. Betaine can support one homocysteine-remethylation pathway, but a common MTHFR variant alone does not establish that you need TMG or identify a dose.

It is also essential to separate common variants from rare severe inherited MTHFR deficiency. The latter is a specialist-managed metabolic disorder, not simply a different name for carrying a common variant.

What does methylation mean here?

Methylation means transferring a methyl group between molecules. These reactions contribute to many aspects of metabolism. They are regulated processes, rather than one tank that should always be filled as high as possible.

In the betaine pathway, BHMT uses betaine to help remethylate homocysteine to methionine. Betaine becomes dimethylglycine. The liver and kidneys are important tissues for this route. [1] [2]

Two remethylation routes, different nutrient roles

Pathway or nutrient	Role relevant to this question	What not to infer
Betaine / BHMT	Uses betaine as a methyl donor for homocysteine remethylation	That it replaces all folate and B12 functions
Folate and B12-dependent remethylation	Another route for recycling homocysteine	That a betaine capsule treats a deficiency in either vitamin
Choline	A precursor of betaine with additional biological roles	That TMG is nutritionally interchangeable with choline
Methionine and SAM-related metabolism	Part of the wider methyl-group network	That more of every methyl donor must be better

Reviews of one-carbon metabolism explain these connections and the broader consequences of methyl-donor status. They provide a mechanism, rather than a diagnosis from a supplement symptom checklist. [3] [4]

Common MTHFR variants are not a treatment plan

C677T and A1298C are common names seen in consumer genetic reports. A report can identify a variant, but it does not by itself establish the cause of an elevated homocysteine result, fatigue or another symptom.

Even when a variant affects enzyme function, the clinical situation also includes diet, B-vitamin status, renal function and other factors. A decision should therefore be tied to the actual problem rather than the presence of the gene name. The result should not be presented as a universal instruction to take a methylated vitamin or a particular TMG amount.

A CrossFit betaine study examined MTHFR-genotype questions without establishing a clear genotype-dependent response that could serve as a universal dose rule. Its exercise population also differs from a patient being assessed for a nutrient deficiency. [5]

What “bypassing MTHFR” actually means

MTHFR contributes to folate metabolism. BHMT is a different enzyme using betaine to remethylate homocysteine, particularly in liver and kidney tissue. Saying that the BHMT route does not depend on MTHFR describes that reaction; it does not show that all folate-related functions can be skipped or that a person’s whole methylation network has been repaired. ^{[1] [2]}

A useful way to think about the routes is as parallel contributions to a wider network. Changing one input can affect a measured metabolite without supplying every role of the other nutrients. Folate, B12 and choline should therefore not be treated as optional simply because a TMG capsule can influence homocysteine.

Common C677T/A1298C results and folic acid

The CDC’s current MTHFR guidance states that people with common variants can process folic acid and that a common variant is not a reason to avoid it. It distinguishes those common findings from rare severe variants with major clinical effects.

This matters because an online “blocked pathway” metaphor can suggest complete loss of function or a need to avoid a standard nutrient. A consumer genotype alone cannot establish either conclusion. Individual care still depends on the clinical question, nutritional status and relevant findings, rather than a supplement protocol attached to a gene name.

Rare severe MTHFR deficiency is different

Severe inherited MTHFR deficiency can disrupt remethylation profoundly and require early diagnosis and specialist treatment. The 2026 revision of remethylation-disorder guidelines emphasizes betaine in that specific clinical setting, alongside diagnosis-specific management. [6]

Disease-specific registries and safety studies provide additional evidence about prescribed betaine within broader care. These populations may use medical doses and laboratory monitoring that have little resemblance to an ordinary wellness supplement routine. [7] [8]

This evidence should remain accessible, but it should not be used to tell every person with a common variant that they have the same disorder or need the same treatment.

TMG, folate and B12: why one does not replace another

A combined trial using betaine, folic acid, B6 and B12 lowered homocysteine in adults with elevated levels. It cannot identify the contribution of each component or establish that one could be omitted safely. [9]

If a B12 or folate deficiency is present, it needs appropriate evaluation and treatment. A fall in homocysteine after taking a methyl donor does not demonstrate that all consequences of a deficiency have been addressed.

Can TMG replace choline?

No. Choline has functions beyond being a betaine precursor. A controlled feeding analysis showed that plasma choline and betaine helped distinguish levels of dietary choline intake, but it did not establish that taking TMG supplies all of choline’s roles. [10]

Food intake belongs in the discussion, but a supplement stack should not be used as a shortcut around a nutritional assessment. Our food guide separates betaine values from total choline.

What about COMT and “overmethylation”?

A commonly discussed genetic result cannot diagnose the cause of anxiety, insomnia or a headache. The available evidence does not establish a universally valid TMG dose based on COMT status alone.

If symptoms appear after changing supplements, record the actual amounts and other changes, pause a suspected trigger and seek assessment when needed. Labeling every symptom as an excess or shortage of methylation can obscure more useful explanations.

Methylation is not the same as biological-age reversal

DNA methylation patterns, methyl-donor metabolism and measured clinical aging outcomes are related research topics, but they are not interchangeable. A betaine capsule providing a methyl donor does not establish that a person’s epigenetic age will improve.

The prominent exercise-and-betaine geroprotection paper combined human exercise profiling with direct betaine experiments in mice. It did not demonstrate human age reversal from a TMG supplement. [11]

Four common situations, four different questions

Situation	The useful question	What the result does not decide
Common MTHFR variant, no defined clinical problem	Is there a reason for further assessment or any change at all?	It does not automatically establish a TMG requirement
Elevated homocysteine	What explains it, and which intervention fits the cause and wider risk profile?	The number alone does not select one methyl donor or dose
Diagnosed rare severe remethylation disorder	What specialist-directed treatment and monitoring are needed?	A retail wellness guide cannot replace the metabolic team’s plan
Symptoms after starting several supplements	Which exposure changed, and are there other explanations?	Symptoms do not diagnose COMT-related overmethylation or establish a corrective stack

For rare severe disease, guidance supports disease-specific betaine treatment and monitoring. That is valuable medical evidence, but it should not be used to label a large share of the population as having the same disorder. ^[6]

Can an epigenetic-age test tell you the TMG dose?

A DNA methylation clock and the metabolic reactions using methyl donors are related to different questions. A clock score does not measure a simple reservoir that can be filled to a target by taking more TMG. Direct evidence would be needed to establish that a particular supplement regimen reliably changes a clinically meaningful aging outcome.

The same caution applies to an internet methylation “score.” Before acting, ask what was measured, whether the test has been validated for this decision and whether the proposed treatment has been compared with an appropriate control. Mechanistic vocabulary cannot supply those missing steps.

For a supplement decision, start with the actual problem, review the full regimen and choose an outcome that the relevant human evidence measures. The homocysteine guide and safety guide are more useful next steps than a universal genotype-based capsule formula.

A parallel pathway is useful chemistry, not a diagnosis

BHMT provides a betaine-dependent route from homocysteine to methionine. Folate- and B12-dependent remethylation is a separate route. Describing TMG as a bypass can explain this relationship, but the metaphor becomes misleading if it suggests that a common gene variant makes the rest of nutrition unnecessary.

Severe inherited MTHFR deficiency is a rare clinical disorder with specialist treatment evidence. The early-treatment analysis and clinical guidance concern that setting, not every person carrying C677T or A1298C. A favourable treatment history in severe disease should not become a universal genotype-based supplement prescription. ^[12]

For a common variant, the useful question is whether there is a clinically relevant problem and what explains it. A gene result, a symptom such as fatigue and a homocysteine measurement provide different information. Review the phenotype and nutrient context rather than treating one genotype as proof that a specific TMG amount is required. The homocysteine guide keeps the measured human effect in view.

A more useful decision framework

Identify the clinical or nutritional question first. Then consider the relevant laboratory findings, diet, medicines and exact supplement formula. Use the homocysteine guide for the human outcome data and the NMN guide for precursor-pairing claims.

Our DoNotAge Pure TMG review covers a clearly labeled capsule option. Choosing a good product and establishing that you personally need it remain separate decisions.

Sources and next steps

Browse the complete 415-publication TMG Data Center for the original studies, methods, disclosures and limitations. The numbered references below identify the sources used for this article; the full library also retains supporting and null evidence.

Continue by question: TMG Dosage Guide: Study Doses and Capsule Calculations · TMG Side Effects: Cholesterol, Digestion and Safety · TMG and NMN: Do You Need Both, and What Ratio? · TMG for Homocysteine: Dose, Results and Limitations.

Our recommended TMG product

DoNotAge Pure TMG — 5/5 editorial rating

Our first choice for a straightforward single-active capsule: 500 mg TMG per capsule, a vegan capsule and 60 or 366 capsules. The score assesses the formula, label clarity and practical product choice; clinical evidence is judged separately.

Read the full evidence-led review · View at DoNotAge. Use BB10 for 10% off eligible standalone products; confirm current checkout terms.

Affiliate disclosure: Biohack Blueprint may earn a commission from qualifying purchases. This is a desk-based editorial recommendation, not an independent batch assay or a promise of a health outcome.